Last updated: 2026-09-16 10:32:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
NewGenIvf Group Limited (NIVF) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.87, with a market capitalisation of $1.98M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.81 to $1,539.00. This page covers its latest market performance, valuation, price trends and company information.
$1.98M | |
$0.84 | |
$1,771,200.00 | |
$0.81 | |
$0.84 | |
728.00 | |
471.99K | |
-- | |
$1,539.00 | |
$0.81 | |
-- | |
-- |
NewGenIvf Group Limited (NIVF) is trading at $0.87 in pre-market trading as of 2026-09-16 10:29:00, up 3.81% ($0.03) from the previous close of $0.84
Pre-market trading shows how investors are pricing NIVF before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, NewGenIvf Group Limited (NIVF) moved from $1.14 to $0.87, representing a decline of 23.51% ($0.27).
The stock traded between $0.81 and $1.22 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 113.96 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.0%
NIVF is currently trading at $0.87, placing it 0.0% of the way from its 52-week low of $0.81 to its 52-week high of $1,539.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
| Employees | 87 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of NewGenIvf Group Limited (NIVF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.